Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa.
- 1 September 2001
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 358 (9287) , 1027-8
- https://doi.org/10.1016/S0140-6736(01)06227-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Resistance to Trimethoprim-SulfamethoxazoleClinical Infectious Diseases, 2001
- Primary Prevention With Cotrimoxazole for HIV-1–Infected Adults: Results of the Pilot Study in Dakar, SenegalJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Emergence of Trimethoprim‐Sulfamethoxazole Resistance in the AIDS EraThe Journal of Infectious Diseases, 1999
- Co-trimoxazole in HIV-1 infectionThe Lancet, 1999
- Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trialThe Lancet, 1999
- Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Colonization by Streptococcus pneumoniae among Human Immunodeficiency Virus-Infected Adults: Prevalence of Antibiotic Resistance, Impact of Immunization, and Characterization by Polymerase Chain Reaction with BOX Primers of Isolates from Persistent S. pneumoniae CarriersThe Journal of Infectious Diseases, 1997
- Risk Factors for Isolation of Streptococcus pneumoniae with Decreased Susceptibility to Penicillin G from Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Co-trimoxazole for childhood febrile illness in malaria-endemic regionsThe Lancet, 1991
- Cutaneous Reactions to Trimethoprim-Sulfamethoxazole in African Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987